Contract 80JSC023FA161
Sti Legacy, Inc. · National Aeronautics And Space Administration · July 16, 2024
Sti Legacy, Inc. was awarded a federal contract by National Aeronautics And Space Administration on July 16, 2024 for $675,000 (current value) of work in research and development in biotechnology (except nanobiotechnology). Performance is in Lexington, KY. This is a task or delivery order issued under parent IDIQ 80JSC023DA015. It uses firm fixed-price contract pricing. If all options are exercised, the contract could reach $675,000.
Contract details
- PIID
- 80JSC023FA161
- Parent IDIQ
- 80JSC023DA015
- Award type
- Delivery Order
- Pricing
- Firm Fixed Price
- Competition
- Full And Open Competition
- NAICS
- 541714 · Research And Development In Biotechnology (Except Nanobiotechnology)
- Product / service
- Space R&D Services; Space Flight, Research And Supporting Activities; Experimental Development
- Place of performance
- Lexington, KY
- First action
- July 16, 2024
Description
DE-SCOPE ACTION - IN-SPACE PRODUCTION OF ORGANS VIA VOLUMETRIC ADDITIVE MANUFACTURING FOR OA DIRECTORATE
Modification timeline
-
July 16, 2024Mod P00005 · Other Administrative Action$675.4K
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Melanie Sauer & Associates Llc | National Aeronautics And Space Administration | March 23, 2026 | $110.0K |
| Sti Legacy, Inc. | National Aeronautics And Space Administration | March 11, 2026 | $0 |
| National Stem Cell Foundation Inc. | National Aeronautics And Space Administration | February 17, 2026 | $1.68M |
| Redwire Space Technologies, Inc. | National Aeronautics And Space Administration | February 13, 2026 | $415.6K |
| Redwire Space Technologies, Inc. | National Aeronautics And Space Administration | February 5, 2026 | $3.23M |
| Aspera Biomedicines, Inc. | National Aeronautics And Space Administration | January 30, 2026 | $3.24M |
Top contractors in NAICS 541714
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Amgen USA Inc | 1 | $59.99M |
| 2 | Vericel Corporation | 1 | $34.88M |
| 3 | Spectral Md, Inc. | 1 | $31.67M |
| 4 | Ppd Development Lp | 6 | $31.12M |
| 5 | L3 Technologies, Inc. | 1 | $22.00M |
| 6 | Technical Resources International, Inc. | 6 | $21.80M |
| 7 | Abbott Laboratories | 1 | $21.01M |
| 8 | Paratek Pharmaceuticals, Inc | 1 | $17.47M |
| 9 | Ossium Health, Inc. | 1 | $12.39M |
| 10 | Rho Federal Systems Division Inc | 1 | $8.00M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract 80JSC023FA161?
Contract 80JSC023FA161 is a federal contract awarded to Sti Legacy, Inc. by National Aeronautics And Space Administration on July 16, 2024 for $675,000 of work classified under RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY). It has been modified 0 times since the base award.
Who won contract 80JSC023FA161?
Sti Legacy, Inc. won contract 80JSC023FA161 from National Aeronautics And Space Administration.
How much is contract 80JSC023FA161 worth?
Contract 80JSC023FA161 has obligated $0 to date but carries a potential ceiling of $675,000 if fully funded and all options are exercised.